Sign In
Buy CERS
$2.66
-0.0400 (-1.48%)
At Close: Jun 03, 2026
Bradley L. Radoff Announces Intent to Withhold Votes from Chair and CEO William Greenman and Director Ann Lucena
11:35am, Wednesday, 27'th May 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff, a significant shareholder of Cerus Corporation (NASDAQ: CERS) (“Cerus” or the “Company”), today announced his intention to withhold support for the
Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis
07:51am, Sunday, 10'th May 2026
Cerus' Q1 2026 product revenues grew another 24% YoY. This was mainly thanks to strong platelet demand and rapid IFC adoption. Management raised its 2026 product revenue guidance to $227-$231 million,
Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript
04:21am, Friday, 01'st May 2026
Cerus Corporation (CERS) Q1 2026 Earnings Call Transcript
Cerus Corporation Announces First Quarter 2026 Financial Results
04:01pm, Thursday, 30'th Apr 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for the first quarter ended March 31, 2026, and provided a business update. “We delivered a stron
Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
08:00am, Monday, 27'th Apr 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with Établissement Français du Sang (EFS), the French Blood Establ
Critical Analysis: Akanda (NASDAQ:AKAN) and Cerus (NASDAQ:CERS)
01:29am, Friday, 17'th Apr 2026
Cerus (NASDAQ: CERS - Get Free Report) and Akanda (NASDAQ: AKAN - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the
Cerus Corporation to Release First Quarter 2026 Financial Results on April 30, 2026
04:01pm, Thursday, 16'th Apr 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2026 financial results will be released on Thursday, April 30, 2026, after the close of the st
Kevin Dennis Green Sells 127,544 Shares of Cerus (NASDAQ:CERS) Stock
06:04am, Wednesday, 18'th Mar 2026
Cerus Corporation (NASDAQ: CERS - Get Free Report) CFO Kevin Dennis Green sold 127,544 shares of the company's stock in a transaction dated Thursday, March 12th. The shares were sold at an average pri
Vivek Jayaraman Sells 165,200 Shares of Cerus (NASDAQ:CERS) Stock
05:30am, Wednesday, 18'th Mar 2026
Cerus Corporation (NASDAQ: CERS - Get Free Report) COO Vivek Jayaraman sold 165,200 shares of the stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $1.66, for
Chrystal Jensen Sells 113,008 Shares of Cerus (NASDAQ:CERS) Stock
04:58am, Wednesday, 18'th Mar 2026
Cerus Corporation (NASDAQ: CERS - Get Free Report) insider Chrystal Jensen sold 113,008 shares of the stock in a transaction that occurred on Wednesday, March 12th. The shares were sold at an average
Cerus Appoints Vivek Jayaraman as President and Chief Executive Officer
04:05pm, Monday, 16'th Mar 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that Vivek Jayaraman, Cerus' chief operating officer, will be promoted to president and chief executive officer, effe
Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference
02:34am, Monday, 09'th Mar 2026
Cerus (NASDAQ: CERS) executives used a presentation and fireside chat at the TD Cowen Healthcare Conference to reiterate the company's focus on making its INTERCEPT Blood System a global standard of c
Cerus's Record 2025 Sets It Up For Another Leg Higher
09:44am, Thursday, 05'th Mar 2026
CERS' INTERCEPT platform (kits + illuminators) is scaling globally, with record 2025 results. They've also grown their adoption across ~40 countries. INT200 received European approval and launched. Th
Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript
06:27pm, Monday, 02'nd Mar 2026
Cerus Corporation (CERS) Q4 2025 Earnings Call Transcript
Cerus Corporation Announces Full-Year and Fourth Quarter 2025 Financial Results
04:01pm, Monday, 02'nd Mar 2026
CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for its full year and fourth quarter ended December 31, 2025. “Our strong 2025 results reflect ou
